More than 100 years after the discovery of insulin galvanized our field, diabetes research and care remain a central part of endocrinology. Diabetes Awareness Month offers the opportunity to reflect on the importance of our research and clinical care to millions of people around the globe.
For the 540 million people worldwide living with diabetes, breakthroughs in research and treatment can lead to concrete improvements in outcomes and quality of life. I am proud of the many resources the Society provides to help diabetes researchers and clinicians excel.
To provide the latest information on diabetes pharmacotherapy management, we created a virtual cohort class for clinicians to learn in a small group environment. Thirty clinicians were invited to the first cohort, “Mastering Pharmacotherapy Management of Type 2 Diabetes,” which took place this summer. Participants discussed prerecorded lectures during live virtual, case-based sessions and via an online discussion board. Later this year, case-based course modules on the evolving role of the endocrinologist in type 2 diabetes pharmacotherapy management, managing cardiovascular risks, newer pharmacotherapies, and diabetes and obesity will be offered more widely in our Center for Learning.
We offer a variety of diabetes educational content that you can access at your convenience from anywhere in the world, including recordings of Clinical Endocrinology Update 2023 and ENDO 2023 sessions on topics such as beta cell autophagy and insulin secretion. Our webinars cover important topics such as how diabetes technology can help address healthcare disparities. I encourage you to browse our Center for Learning for topics that interest you.
We also work to bring diabetes education to members around the world. In August, we held our ninth annual Dimensions in Diabetes event in Mumbai, India. This event, held in conjunction with Mediquest, gives hundreds of clinicians in India an opportunity to interact with world-renowned faculty members on important diabetes topics, such as preservation of kidney function and management of complications in a pediatric population.
As a community, we can leverage advances in diabetes research and clinical care to improve the lives of the patients and families who need them the most. As we mark Diabetes Awareness Month, I find myself in awe of our members’ many contributions in the diabetes realm.
Whenever you want to consult a group of peers about a diabetes topic, our secure online medical collaborative community, DocMatter, provides a venue to pose questions or share cases. Members have discussed diverse topics like the use of statins in type 1 diabetes and atherosclerotic cardiovascular disease risk in our community. I enjoy seeing the knowledge sharing and interaction between our members on this platform.
Our Endocrine Feedback Loop podcast gives you a chance to listen to speakers delve into journal articles. Recent episodes have explored how type 1 diabetes affects pancreas size and the glycemic gap in hospitalized patients with COVID-19.
The Society’s peer-reviewed journals curated important diabetes research in a special thematic issue. Articles in the diabetes thematic issue examine topics such as enhanced endosomal signaling and densensitization of GLP-1R in rat pancreatic beta cells as well as progress toward a type 1 diabetes treatment using the implantation of stem cell-derived islets.
Our members are having a real-world impact on diabetes treatment and research. The Hypoglycemia Prevention Initiative, a partnership between the Society and Avalere Health, developed a low-cost clinical support decision tool to help primary care providers minimize the impact of hypoglycemia among patients ages 65 and older. The results of the HypoPrevent quality improvement study were published in the Journal of the American Geriatrics Society in September, paving the way for more widespread adoption of the clinical support decision tool.
As a community, we can leverage advances in diabetes research and clinical care to improve the lives of the patients and families who need them the most. As we mark Diabetes Awareness Month, I find myself in awe of our members’ many contributions in the diabetes realm.
Loading ...